AOD 9604 isnt appropriate for everyone, such as those who: Before starting, inform your prescriber if youre taking the following medication to prevent harmful drug interactions: Your licensed clinician should run baseline laboratory tests before starting your dosing, which they must always supervise
Entry level glutathione IVs usually include a moderate dose administered either as a standalone infusion or as part of a basic antioxidant blend
doi: 10.1016/j.aju.2017.11.008 70 AliMMartinezMParekhN
105,106,326 Targeting key signaling pathways, such as TGF-, Wnt, and Notch, and EMT-related transcription factors (e.g., ZEB1, TWIST1) is another strategy under active investigation
There is no clear evidence that AOD-9604 directly activates 3-adrenergic receptors